Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Martin

Showing results (1-10 of 312) with videos related to

Pageof 32
Sort By:
The Lancet. Oncology|June 9, 2018
The LILAC trial and the blooming of anticancer biosimilarsMiguel Martin
Seminars in Oncology|February 1, 2017
IntroductionMiguel Martin
Seminars in Oncology|February 14, 2006
Clinical Experience With Pemetrexed in Breast CancerMiguel Martin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2025
Response to Neoadjuvant Chemotherapy and Breast Cancer SubtypesMiguel Martin
ESMO Open|February 2, 2018
BiosimilarsMiguel Martin
Women'S Health (London, England)|October 7, 2009
Docetaxel, doxorubicin and cyclophosphamide (the TAC regimen): an effective adjuvant treatment for operable breast cancerMiguel Martin
The Lancet. Oncology|July 23, 2017
Tuning up adjuvant endocrine therapy: the TEAM trialMiguel Martin
Lancet (London, England)|May 19, 2009
Unravelling the mystery of the TACT trialMiguel Martin
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|October 20, 2007
Nosologic maps of brain tumor images obtained from combination of different MRI modalitiesMiguel Martin-Landrove
International Journal of Molecular Sciences|April 27, 2024
Regulation of Molecular Biomarkers Associated with the Progression of Prostate CancerMiguel Martin-Caraballo
Pageof 32

Showing results (1-10 of 312) with videos related to

Sort By:
Pageof 32
The Lancet. Oncology|June 9, 2018
The LILAC trial and the blooming of anticancer biosimilarsMiguel Martin
Seminars in Oncology|February 1, 2017
IntroductionMiguel Martin
Seminars in Oncology|February 14, 2006
Clinical Experience With Pemetrexed in Breast CancerMiguel Martin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2025
Response to Neoadjuvant Chemotherapy and Breast Cancer SubtypesMiguel Martin
ESMO Open|February 2, 2018
BiosimilarsMiguel Martin
Women'S Health (London, England)|October 7, 2009
Docetaxel, doxorubicin and cyclophosphamide (the TAC regimen): an effective adjuvant treatment for operable breast cancerMiguel Martin
The Lancet. Oncology|July 23, 2017
Tuning up adjuvant endocrine therapy: the TEAM trialMiguel Martin
Lancet (London, England)|May 19, 2009
Unravelling the mystery of the TACT trialMiguel Martin
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|October 20, 2007
Nosologic maps of brain tumor images obtained from combination of different MRI modalitiesMiguel Martin-Landrove
International Journal of Molecular Sciences|April 27, 2024
Regulation of Molecular Biomarkers Associated with the Progression of Prostate CancerMiguel Martin-Caraballo
Pageof 32